Abstract:Diabetic foot ulcer is a devastating complication of diabetes mellitus and significant cause of mortality and morbidity all over the world and can be complex and costly. The development of foot ulcer in a diabetic patient has been estimated to be 19%-34% through their lifetime. The pathophysiology of diabetic foot ulcer consist of neuropathy, trauma and, in many patients, additional peripheral arterial disease. In particular, diabetic neuropathy leads to foot deformity, callus formation, and insensitivity to trauma or pressure. The standard algorithms in diabetic foot ulcer management include assessing the ulcer grade classification, surgical debridement, dressing to facilitate wound healing, off-loading, vascular assessment (status and presence of a chance for interventional vascular correction), and infection and glycemic control. Although especially surgical procedures are sometimes inevitable, they are poor predictive factors for the prognosis of diabetic foot ulcer. Different novel treatment modalities such as nonsurgical debridement agents, oxygen therapies, and negative pressure wound therapy, topical drugs, cellular bioproducts, human growth factors, energy-based therapies, and systematic therapies have been available for patients with diabetic foot ulcer. However, it is uncertain whether they are effective in terms of promoting wound healing related with a limited number of randomized controlled trials. This review aims at evaluating diabetic foot ulcer with regard to all aspects. We will also focus on conventional and novel adjunctive therapy in diabetic foot management. Key Words: Diabetic foot ulcer, Peripheric artery disease, Macrovascular complications, Neuropathy, Wagner classification, Intralesionar growth factor treatment Core Tip: Diabetic foot ulcers (DFU) are one of the most common problems and devastating complications of diabetes, and affect 15% of all diabetic patients and result in significant morbidity, mortality, and financial burdens. The management of DFU is usually complex and challenging to clinicians in clinical practice. This review article aims at summarizing the etiopathogenesis and classification of DFU. It also highlights novel adjunctive treatment modalities as well as conventional management for DFU. Citation: Akkus G, Sert M. Diabetic foot ulcers: A devastating complication of diabetes mellitus continues non-stop in spite of new medical treatment modalities. World J Diabetes 2022; 13(12): 1106-1121 URL: https://www.wjgnet.com/1948-9358/full/v13/i12/1106.htm DOI: https://dx.doi.org/10.4239/wjd.v13.i12.1106

Progress in Medical Therapy for Diabetic Foot Ulcer

Successful Treatment of a Patient with Complicated Diabetic Foot Wound

Diabetic foot ulcer: Challenges and future

Stem Cell-Based Therapy for Diabetic Foot Ulcers

Advances in stem cell therapy for diabetic foot

Advances in microcirculation monitoring and physical factor therapy techniques in diabetic foot

Recent advances in the adjunctive management of diabetic foot ulcer: Focus on noninvasive technologies

Diagnostics and treatment of the diabetic foot

Hyperbaric Oxygen Therapy for Diabetic Foot Ulcers

Physical therapy in diabetic foot ulcer: Research progress and clinical application

Diabetic foot ulcers: A devastating complication of diabetes mellitus continues non-stop in spite of new medical treatment modalities

Stem Cell Therapy for Diabetic Foot Ulcers: Theory and Practice

Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research

Bone marrow-derived mesenchymal stem cells: A promising therapeutic option for the treatment of diabetic foot ulcers

Growth factors in the pathogenesis of diabetic foot ulcers.

Efficiency of Stem Cell Based Therapy in the Treatment of Diabetic Foot Ulcer: a Meta-Analysis.

Physiological and Pathophysiological Aspects of Diabetic Foot Ulcer and its Treatment Strategies

Experimental treatments in clinical trials for diabetic foot ulcers: wound healers in the pipeline

Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities

Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects

Diverse Antibacterial Treatments beyond Antibiotics for Diabetic Foot Ulcer Therapy